Gastrointestinal Cancer,Pancreatic Cancer Phase 2 Study: Rucaparib-resistant BRCA/PALB2 Pancreatic Cancer Treatment Mar 27, 2023
Gastric Cancer,Gastrointestinal Cancer Impact of Skipping Bevacizumab on IMBRAVE150 HCC Treatment Efficacy Mar 14, 2023
Colorectal Cancer,Gastrointestinal Cancer Breakwater Safety Lead-In Improves Outcomes in BRAFV600E mCRC Mar 13, 2023
Colorectal Cancer,Gastrointestinal Cancer Global Study Shows Fruquintinib Improves HRQoL in FRESCO-2 Trial Mar 13, 2023
Colorectal Cancer,Gastrointestinal Cancer EPOCH Trial: Optimizing Treatment Planning for Patient Subgroups Mar 13, 2023
Gastrointestinal Cancer,Liver Cancer Impact of ADAs on uHCC Treatment in HIMALAYA Phase 3 Study Mar 10, 2023
Gastrointestinal Cancer,Liver Cancer HRQoL Impact of Tislelizumab vs. Sorafenib in First-line uHCC: RATIONALE-301 Mar 10, 2023
Gastrointestinal Cancer,Liver Cancer LEAP-002 Study: Lenvatinib+Pembrolizumab vs Lenvatinib+Placebo in aHCC HRQoL Comparison Mar 10, 2023
